These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 11866439)
21. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia. Barjesteh van Waalwijk van Doorn-Khosrovani S; Spensberger D; de Knegt Y; Tang M; Löwenberg B; Delwel R Oncogene; 2005 Jun; 24(25):4129-37. PubMed ID: 15806161 [TBL] [Abstract][Full Text] [Related]
22. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics. Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045 [TBL] [Abstract][Full Text] [Related]
24. Functional analyses of the TEL-ARNT fusion protein underscores a role for oxygen tension in hematopoietic cellular differentiation. Nguyen-Khac F; Della Valle V; Lopez RG; Ravet E; Mauchauffé M; Friedman AD; Huang LE; Fichelson S; Ghysdael J; Bernard OA Oncogene; 2006 Aug; 25(35):4840-7. PubMed ID: 16547490 [TBL] [Abstract][Full Text] [Related]
25. TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL. Irvin BJ; Wood LD; Wang L; Fenrick R; Sansam CG; Packham G; Kinch M; Yang E; Hiebert SW J Biol Chem; 2003 Nov; 278(47):46378-86. PubMed ID: 12960174 [TBL] [Abstract][Full Text] [Related]
26. IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo. Kröger A; Dallügge A; Kirchhoff S; Hauser H Oncogene; 2003 Feb; 22(7):1045-56. PubMed ID: 12592391 [TBL] [Abstract][Full Text] [Related]
27. v-SRC specifically regulates the nucleo-cytoplasmic delocalization of the major isoform of TEL (ETV6). Lopez RG; Carron C; Ghysdael J J Biol Chem; 2003 Oct; 278(42):41316-25. PubMed ID: 12893822 [TBL] [Abstract][Full Text] [Related]
28. The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells. Starkova J; Madzo J; Cario G; Kalina T; Ford A; Zaliova M; Hrusak O; Trka J Clin Cancer Res; 2007 Mar; 13(6):1726-35. PubMed ID: 17325341 [TBL] [Abstract][Full Text] [Related]
29. TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia. Zuna J; Ford AM; Peham M; Patel N; Saha V; Eckert C; Köchling J; Panzer-Grümayer R; Trka J; Greaves M Clin Cancer Res; 2004 Aug; 10(16):5355-60. PubMed ID: 15328172 [TBL] [Abstract][Full Text] [Related]
30. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival. Xin H; Geng Y; Pramanik R; Choubey D J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788 [TBL] [Abstract][Full Text] [Related]
31. Difference gel electrophoresis analysis of Ras-transformed fibroblast cell-derived exosomes. Ji H; Erfani N; Tauro BJ; Kapp EA; Zhu HJ; Moritz RL; Lim JW; Simpson RJ Electrophoresis; 2008 Jun; 29(12):2660-71. PubMed ID: 18494037 [TBL] [Abstract][Full Text] [Related]
32. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Hock H; Meade E; Medeiros S; Schindler JW; Valk PJ; Fujiwara Y; Orkin SH Genes Dev; 2004 Oct; 18(19):2336-41. PubMed ID: 15371326 [TBL] [Abstract][Full Text] [Related]
33. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia. Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750 [TBL] [Abstract][Full Text] [Related]
34. TEL/JAK2 tyrosine kinase inhibits DNA repair in the presence of amifostine. Gloc E; Warszawski M; Młynarski W; Stolarska M; Hoser G; Skorski T; Błasiak J Acta Biochim Pol; 2002; 49(1):121-8. PubMed ID: 12136932 [TBL] [Abstract][Full Text] [Related]
35. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells. Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001 [TBL] [Abstract][Full Text] [Related]
36. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Fenrick R; Wang L; Nip J; Amann JM; Rooney RJ; Walker-Daniels J; Crawford HC; Hulboy DL; Kinch MS; Matrisian LM; Hiebert SW Mol Cell Biol; 2000 Aug; 20(16):5828-39. PubMed ID: 10913166 [TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor 2 restrains Ras-driven proliferation of malignant cells by triggering RhoA-mediated senescence. Costa ET; Forti FL; Matos TG; Dermargos A; Nakano F; Salotti J; Rocha KM; Asprino PF; Yoshihara CK; Koga MM; Armelin HA Cancer Res; 2008 Aug; 68(15):6215-23. PubMed ID: 18676845 [TBL] [Abstract][Full Text] [Related]
38. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells. Voulgari A; Voskou S; Tora L; Davidson I; Sasazuki T; Shirasawa S; Pintzas A Mol Cancer Res; 2008 Jun; 6(6):1071-83. PubMed ID: 18567809 [TBL] [Abstract][Full Text] [Related]